1 to 4 of 4 literature results

• Compatibility of toluidine blue with laser microdissection and saturation labeling DIGE.

  Tissue fixation and staining protocols for laser microdissection are frequently not fully compatible with subsequent proteomic analysis. We compared t…

  Authors: Chandra Kirana, Teresa Ward, T William Jordan, Pisana Rawson, Janice Royds, Hong Jun Shi, Richard Stubbs, Kylie Hood

  Source: Proteomics. 2009 Jan

  View Full Text

• Nuclear localization of Y-box factor YB1 requires wild-type p53.

  Nuclear localization and high levels of the Y-box binding protein YB1 appear to be important indicators of drug resistance and tumor prognosis. YB1 al…

  Authors: You Fang Zhang, Craig Homer, Sara J Edwards, Lynne Hananeia, Annette Lasham, Janice Royds, Philip Sheard, Antony W Braithwaite

  Source: Oncogene. 2003 May 8

  View Full Text

• Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

  The adenovirus mutant ONYX-015 is in phase III clinical trials as a novel antitumor therapy. Its apparent efficacy is thought to be due to its ability…

  Authors: Sara J Edwards, Brett R Dix, Colleen J Myers, Deirdre Dobson-Le, Lily Huschtscha, Merilyn Hibma, Janice Royds, Antony W Braithwaite

  Source: Journal of virology. 2002 Dec

  View Free Full Text

• Molecular markers and long-term survivors of glioblastoma multiforme.

  Authors: Michael J McKay, Peter MacCallum, Roger R Reddel, Janice Royds

  Source: Cancer journal (Sudbury, Mass.). 2004 Sep-Oct

  View Full Text